Statement: Zantac Litigation - Gross Case
June 29, 2024
June 29, 2024
LONDON, England, June 29 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:
GSK plc (LSE/NYSE: GSK) has reached a confidential settlement with Martin Gross resolving the case he filed in Illinois state court.
GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK.
Following the 16 epidemiological studies looking at human data regarding the use of ranitidine, the scientif . . .
GSK plc (LSE/NYSE: GSK) has reached a confidential settlement with Martin Gross resolving the case he filed in Illinois state court.
GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK.
Following the 16 epidemiological studies looking at human data regarding the use of ranitidine, the scientif . . .